Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection

Clinical and Experimental Rheumatology

Volumn 31, Issue 5, 2013, Pages 0816-

  Giannitti, C ^a   Fineschi, I ^a   Frediani, B ^a   Fioravanti, A ^a   Galeazzi, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCINEURIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHILIN B; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; METHOTREXATE; PREDNISONE; TACROLIMUS; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VIRUS RNA; ANTIRHEUMATIC AGENT; CYCLOSPORIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CELLULITIS; CONCURRENT INFECTION; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; ENZYME INHIBITION; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HEPATITIS C; HEPATOGRAPHY; HUMAN; IMMUNE DEFICIENCY; LETTER; LIVER FUNCTION; LIVER TOXICITY; LOW DRUG DOSE; MALE; MONOTHERAPY; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIREMIA; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; ARTHRITIS, RHEUMATOID; COMPLICATION; DRUG COMBINATION; HEPATITIS C, CHRONIC; IMMUNOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84884919138     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. MAILLEFERT JF, MULLER G, FALGARONE G et al.: Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 635-7.
2. MOK MY, NG WL, YUEN MF, WONG RW, LAU CS: Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 2000; 18: 363-8.
3. GALEAZZI M, BELLISAI F, GIANNITTI C, MANGANELLI S, MOROZZI G, SEBASTIANI GD: Safety of Cyclosporine A in HCV infected patients: experience with Cyclosporine A in patients affected by rheumatological disorders and concomitant HCV infection. Ann N Y Acad Sci 2007; 1110: 544-9.
4. GIANNITTI C, BELLISAI F, FERRI C, GALEAZZI M: Treatment strategies for a patient with rheumatoid arthritis and hepatitis C. Expert Opin Pharmacother 2009; 10: 579-87.
5. GIANNITTI C, BENUCCI M, CAPORALI R et al.: Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection. Int J Immunopathol Pharmacol 2009; 22: 543-6.
6. FERRI C, FERRACCIOLI G, FERRARI D et al.; for the GISEA group: Anti-TNF-a therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. J Rheumatol 2008; 35: 1944-9.
7. NAGASHIMA T, MARUYAMA A, KAMATA Y, MINOTA S: Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection. Rheumatol Int 2012; 32: 2231-2.
8. IEBBA F, DI SORA F, TARASI A, LETI W, MONTELLA T, MONTELLA F: Case Report: safety and efficacy of tocilizumab in a patient with rheumatoid arthritis and chronic hepatitis C. Case Report Med 2012; 2012: 212-381.
9. DRAGONAS C, EHRENSTEIN B, FLECK M: Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection. Rheumatology 2012; 51: 1520-1.
10. MORI S, FUJIYAMA S: Comment on: Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection. Rheumatology 2012; 51: 2300-2.